LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications.

    Smetana, Karel / Brábek, Jan

    In vivo (Athens, Greece)

    2020  Volume 34, Issue 3 Suppl, Page(s) 1589–1592

    Abstract: COVID-19 is viral respiratory infection with frequently fatal lung complications in the elderly or ... signaling pathway can attenuate such a cytokine storm and can be beneficial for patients with COVID-19 in danger ... related to an increased level of interleukin-6 (IL6). Therapeutic targeting of the interleukin-6 ...

    Abstract COVID-19 is viral respiratory infection with frequently fatal lung complications in the elderly or in people with serious comorbidities. Lung destruction appears to be associated with a cytokine storm related to an increased level of interleukin-6 (IL6). Therapeutic targeting of the interleukin-6 signaling pathway can attenuate such a cytokine storm and can be beneficial for patients with COVID-19 in danger of pulmonary failure. This article demonstrates the importance of IL6 in progression of disease and the possibility of inhibition of IL6 signaling in COVID-19 therapy.
    MeSH term(s) Anti-Inflammatory Agents/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19 ; Clinical Trials as Topic ; Coronavirus Infections/complications ; Coronavirus Infections/drug therapy ; Coronavirus Infections/immunology ; Coronavirus Infections/physiopathology ; Cytokine Receptor gp130/antagonists & inhibitors ; Cytokine Receptor gp130/physiology ; Cytokine Release Syndrome/drug therapy ; Cytokine Release Syndrome/etiology ; Cytokine Release Syndrome/immunology ; Cytokine Release Syndrome/physiopathology ; Humans ; Immunotherapy ; Indoles/therapeutic use ; Interleukin-6/antagonists & inhibitors ; Interleukin-6/physiology ; Lung/pathology ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/immunology ; Pneumonia, Viral/physiopathology ; Receptors, Interleukin-6/antagonists & inhibitors ; Receptors, Interleukin-6/physiology ; Receptors, Virus/drug effects ; Signal Transduction
    Chemical Substances Anti-Inflammatory Agents ; Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Antiviral Agents ; IL6 protein, human ; Indoles ; Interleukin-6 ; Receptors, Interleukin-6 ; Receptors, Virus ; Cytokine Receptor gp130 (133483-10-0) ; bazedoxifene (Q16TT9C5BK)
    Keywords covid19
    Language English
    Publishing date 2020-06-05
    Publishing country Greece
    Document type Journal Article ; Review
    ZDB-ID 807031-3
    ISSN 1791-7549 ; 0258-851X
    ISSN (online) 1791-7549
    ISSN 0258-851X
    DOI 10.21873/invivo.11947
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications

    Smetana, Karel / Brábek, Jan

    In Vivo

    Abstract: COVID-19 is viral respiratory infection with frequently fatal lung complications in the elderly or ... signaling pathway can attenuate such a cytokine storm and can be beneficial for patients with COVID-19 in danger ... related to an increased level of interleukin-6 (IL6). Therapeutic targeting of the interleukin-6 ...

    Abstract COVID-19 is viral respiratory infection with frequently fatal lung complications in the elderly or in people with serious comorbidities. Lung destruction appears to be associated with a cytokine storm related to an increased level of interleukin-6 (IL6). Therapeutic targeting of the interleukin-6 signaling pathway can attenuate such a cytokine storm and can be beneficial for patients with COVID-19 in danger of pulmonary failure. This article demonstrates the importance of IL6 in progression of disease and the possibility of inhibition of IL6 signaling in COVID-19 therapy.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32503815
    Database COVID19

    Kategorien

To top